These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29112087)

  • 21. Fecal calprotectin, MMP-9, and human beta-defensin-2 levels in pediatric inflammatory bowel disease.
    Kolho KL; Sipponen T; Valtonen E; Savilahti E
    Int J Colorectal Dis; 2014 Jan; 29(1):43-50. PubMed ID: 24077667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Faecal calprotectin as a novel biomarker for differentiating between inflammatory bowel disease and irritable bowel syndrome.
    Chang MH; Chou JW; Chen SM; Tsai MC; Sun YS; Lin CC; Lin CP
    Mol Med Rep; 2014 Jul; 10(1):522-6. PubMed ID: 24788223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serological markers in diagnosis of pediatric inflammatory bowel disease and as predictors for early tumor necrosis factor blocker therapy.
    Olbjørn C; Cvancarova Småstuen M; Thiis-Evensen E; Nakstad B; Vatn MH; Perminow G
    Scand J Gastroenterol; 2017 Apr; 52(4):414-419. PubMed ID: 27887202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bile acid malabsorption assessed by 7 alpha-hydroxy-4-cholesten-3-one in pediatric inflammatory bowel disease: correlation to clinical and laboratory findings.
    Gothe F; Beigel F; Rust C; Hajji M; Koletzko S; Freudenberg F
    J Crohns Colitis; 2014 Sep; 8(9):1072-8. PubMed ID: 24666974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The microbiome reflects diagnosis and predicts disease severity in paediatric onset inflammatory bowel disease.
    Malham M; Lilje B; Houen G; Winther K; Andersen PS; Jakobsen C
    Scand J Gastroenterol; 2019 Aug; 54(8):969-975. PubMed ID: 31329473
    [No Abstract]   [Full Text] [Related]  

  • 26. Fecal pyruvate kinase is not suitable for discrimination between inflammatory bowel disease exacerbation and acute gastroenteritis.
    Czub E; Nowak JK; Moczko J; Mankowski P; Lisowska A; Banaszkiewicz A; Banasiewicz T; Walkowiak J
    Dev Period Med; 2015; 19(2):167-73. PubMed ID: 26384117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fecal lactoferrin, a marker of intestinal inflammation in children with inflammatory bowel disease.
    Borkowska A; Liberek A; Łuczak G; Jankowska A; Plata-Nazar K; Korzon M; Kamińska B
    Acta Biochim Pol; 2015; 62(3):541-5. PubMed ID: 26339799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pancreatitis-associated protein has no additional value as a marker of disease activity in a real-life cohort of IBD patients.
    Bodelier AG; Pierik MJ; van den Heuvel T; Bovee-Oudenhoven IM; de Boer E; Hameeteman W; Masclee AA; Jonkers D
    Eur J Gastroenterol Hepatol; 2014 Aug; 26(8):902-9. PubMed ID: 24915490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimized Sampling Conditions for Fecal Volatile Organic Compound Analysis by Means of Field Asymmetric Ion Mobility Spectrometry.
    Bosch S; El Manouni El Hassani S; Covington JA; Wicaksono AN; Bomers MK; Benninga MA; Mulder CJJ; de Boer NKH; de Meij TGJ
    Anal Chem; 2018 Jul; 90(13):7972-7981. PubMed ID: 29860824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Fecal neutrophil gelatinase-associated lipocalin is a surrogate marker of inflammation in inflammatory bowel disease].
    Zinkevich OD; Mukhametova DD; Abdulganieva DI; Safina NA; Koporulina MO; Odintsova AKh
    Eksp Klin Gastroenterol; 2014; (10):22-7. PubMed ID: 25911926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fecal calprotectin as a promising marker of inflammatory diseases.
    Paduchova Z; Durackova Z
    Bratisl Lek Listy; 2009; 110(10):598-602. PubMed ID: 20017448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fecal hemoglobin and calprotectin are equally effective in identifying patients with inflammatory bowel disease with active endoscopic inflammation.
    Mooiweer E; Fidder HH; Siersema PD; Laheij RJ; Oldenburg B
    Inflamm Bowel Dis; 2014 Feb; 20(2):307-14. PubMed ID: 24374878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The faecal scent of inflammatory bowel disease: Detection and monitoring based on volatile organic compound analysis.
    Bosch S; Wintjens DSJ; Wicaksono A; Kuijvenhoven J; van der Hulst R; Stokkers P; Daulton E; Pierik MJ; Covington JA; de Meij TGJ; de Boer NKH
    Dig Liver Dis; 2020 Jul; 52(7):745-752. PubMed ID: 32402741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
    Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
    World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship of clinical symptoms with biomarkers of inflammation in pediatric inflammatory bowel disease.
    Hoekman DR; Diederen K; Koot BG; Tabbers MM; Kindermann A; Benninga MA
    Eur J Pediatr; 2016 Oct; 175(10):1335-42. PubMed ID: 27573259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Faecal chitinase 3-like-1: a novel biomarker of disease activity in paediatric inflammatory bowel disease.
    Aomatsu T; Imaeda H; Matsumoto K; Kimura E; Yoden A; Tamai H; Fujiyama Y; Mizoguchi E; Andoh A
    Aliment Pharmacol Ther; 2011 Oct; 34(8):941-8. PubMed ID: 21848856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variability of core microbiota in newly diagnosed treatment-naïve paediatric inflammatory bowel disease patients.
    de Meij TGJ; de Groot EFJ; Peeters CFW; de Boer NKH; Kneepkens CMF; Eck A; Benninga MA; Savelkoul PHM; van Bodegraven AA; Budding AE
    PLoS One; 2018; 13(8):e0197649. PubMed ID: 30102706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD.
    De Preter V; Machiels K; Joossens M; Arijs I; Matthys C; Vermeire S; Rutgeerts P; Verbeke K
    Gut; 2015 Mar; 64(3):447-58. PubMed ID: 24811995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fungal and Bacterial Loads: Noninvasive Inflammatory Bowel Disease Biomarkers for the Clinical Setting.
    Sarrabayrouse G; Elias A; Yáñez F; Mayorga L; Varela E; Bartoli C; Casellas F; Borruel N; Herrera de Guise C; Machiels K; Vermeire S; Manichanh C
    mSystems; 2021 Mar; 6(2):. PubMed ID: 33758031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis.
    Klingberg E; Strid H; Ståhl A; Deminger A; Carlsten H; Öhman L; Forsblad-d'Elia H
    Arthritis Res Ther; 2017 Feb; 19(1):21. PubMed ID: 28148281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.